Page last updated: 2024-10-25

deferoxamine and Dysphagia

deferoxamine has been researched along with Dysphagia in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"Patients for this analysis were selected from a previously completed multicenter, randomized, double-blind futility design clinical trial, the Intracerebral Hemorrhage Deferoxamine trial, and underwent a retrospective review of prospectively collected data."5.51Predicting Gastrostomy Tube Placement After Intracerebral Hemorrhage: External Validation of the GRAVo Score. ( Bhanu, G; Carvalho, F; Hasan, S; Heistand, E; Kumar, S; Lin, D; Marchina, S; Minyetty, M; Selim, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lin, D1
Minyetty, M1
Selim, M1
Marchina, S1
Carvalho, F1
Heistand, E1
Bhanu, G1
Hasan, S1
Kumar, S1

Trials

1 trial available for deferoxamine and Dysphagia

ArticleYear
Predicting Gastrostomy Tube Placement After Intracerebral Hemorrhage: External Validation of the GRAVo Score.
    Neurocritical care, 2022, Volume: 37, Issue:2

    Topics: Cerebral Hemorrhage; Deferoxamine; Deglutition Disorders; Gastrostomy; Glasgow Coma Scale; Humans; M

2022